Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PvDBPII-Matrix M1 Vaccine in Healthy Adults Living in the UK
NCT04201431Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jan 2020
- Primary completion
- Jul 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of PvDBPII + Matrix-M1 in vivax malaria, sponsored by University of Oxford. Started Jan 2020; status: completed.
02
Drugs
PvDBPII + Matrix-M1
03
Conditions
vivax malaria
Beyond the preview
Go deeper on NCT04201431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201431.